Program outline now available!
The APLAR 2026 official program is scheduled in the South Korea time zone (UTC+9). To check the program times in your location, use a time zone converter.
As more information becomes available – this page will be updated so please make sure to check back regularly.
Program is best viewed on a desktop or large landscape screen.
Congress Travel Grants
APLAR will award 50 need-based travel stipends to AYR members, covering part of their travel and lodging expenses along with complimentary conference registration.
Cell key:
Industry
Main Program
Poster Viewing
Social Function
| Workshop | |
|---|---|
|
0700-0800 |
REGISTRATION |
|
0800-1030 |
|
|
1030-1045 |
BREAK |
|
1045-1230 |
Musculoskeletal Ultrasound Workshop Day 1 (continues) |
|
1230-1330 |
LUNCH |
|
1330-1500 |
Musculoskeletal Ultrasound Workshop Day 1 (continues) |
|
1500-1515 |
BREAK |
|
1515-1745 |
Musculoskeletal Ultrasound Workshop Day 1 (continues) |
| Concurrent | Concurrent | Concurrent | Concurrent | |||
|---|---|---|---|---|---|---|
|
0800
|
REGISTRATION |
|||||
|
0900-1030
|
|
|
|
Workshop 4 – Enhancing and Implementation of Shared Decision-Making (SDM) in Rheumatology Practice: Tools, Skills & Implementation
View workshop information |
||
|
1030-1045
|
BREAK |
|||||
|
1045-1245
|
Musculoskeletal Ultrasound Workshop Day 2 (continues) |
Workshop 2 – GRAPPA Workshop (continues)
|
Workshop 3 – Clinical review (continues)
|
Workshop 4 – Enhancing and Implementation of Shared Decision-Making (SDM) in Rheumatology Practice: Tools, Skills & Implementation
(continues)
|
||
|
1245-1330
|
LUNCH BREAK |
|||||
|
1330-1500
|
Musculoskeletal Ultrasound Workshop Day 2 (continues) |
Workshop 2 – GRAPPA Workshop (continues)
|
Workshop 3 – Clinical review (continues)
|
Workshop 4 – Enhancing and Implementation of Shared Decision-Making (SDM) in Rheumatology Practice: Tools, Skills & Implementation
(continues)
|
||
|
1500-1700
|
Pre-congress Industry workshop 1
|
Pre-congress Industry workshop 2
|
Pre-congress Industry workshop 3
|
Pre-congress Industry workshop 4
|
||
|
Sponsored by AbbVie
|
||||||
|
1700-1800
|
Opening Ceremony Included in registration. View more information here |
|||||
|
1800-1930
|
Welcome Reception and Official Opening of Exhibition Hall Included in registration. View more information here |
|||||
| Plenary / Concurrent 1 | Concurrent 2 | Concurrent 3 | Concurrent 4 | |
|---|---|---|---|---|
|
0700 |
REGISTRATION
|
|||
|
0830-1000
|
Plenary session 1: State-of-the-Art Management of Rheumatic Diseases
Chairpersons: TBC Rheumatoid Arthritis (RA) Tsutomu Takeuchi SLE Mandana Nikpour Osteoporosis Kenneth Saag |
|||
|
1000-1025 |
BREAK |
Poster viewing |
||
|
1025-1125
|
Morning symposium 1
Title coming soon |
Morning symposium 2
Title coming soon |
Morning symposium 3
Title coming soon |
Morning symposium 4
Title coming soon |
|
Sponsored by Celltrion
|
Sponsored by GSK
|
Sponsored by AbbVie
|
Sponsored by Viatris
|
|
|
1125-1130 |
Transition between sessions |
|||
|
1130-1245 |
Advances and controversies in SLE management (TBC) Coordinated by the APLAR SLE SIG |
COPCORD session
|
Multiomics approach in systemic rheumatic diseases
|
AYR symposium: Crossroads of Inflammation: Unraveling the Gut–Skin–Spine Spectrum in Spondyloarthritis Coordinated by APLAR Young Rheumatologists |
|
Chairpersons: Yoshiya Tanaka and Laniyati Hamijoyo
Update on the management of cutaneous lupus erythematosus Tae-Gyun Kim Management of difficult lupus nephritis Chi Chiu Mok Controversies of glucocorticoid treatment in SLE Sandra Navarra Q&A |
|
Chairpersons: TBC
Multi-Omics Analysis of T Cell Dysfunction in Autoimmune Diseases Keishi Fujio Q&A |
Chairpersons: Babur Salim and Jiuliang Zhao
Ankylosing Spondylitis in 2026: A New Era of Diagnosis and Disease Control Xenofon Baraliakos IBD-Associated Spondylarthritis : A Translational Perspective Lai Shan Tam Q&A |
|
|
1245-1250
|
Transition between sessions |
|||
|
1250-1420 |
|
Lunch symposium 1
Title coming soon |
Lunch symposium 2
|
Lunch symposium 3
|
|
Sponsored by Boehringer Ingelheim
|
||||
|
1420-1425
|
Transition between sessions |
|||
|
1425-1540 |
APLAR – EULAR symposium Coordinated by EULAR – International session |
Redefining Quality of Care: Structural determinants of health, Patient Engagement and Outreach Coordinated by the APLAR Social Commitment & Patient Outreach SIG |
Recent Advances in Upper Extremity Surgery for RA patients
|
Abstract session 1
|
|
Chairpersons: Yoshiya Tanaka and TBC
Diagnosis vs. Classification – the ASAS/SPARTAN 2026 criteria Xenofon Baraliakos Q&A |
|
|
|
|
|
1540-1610 |
BREAK |
Poster viewing |
||
|
1610-1725 |
Osteoarthritis Coordinated by the APLAR Osteoarthritis SIG |
APLAR–PANLAR session International session |
GRAPPA session
|
New Horizons in the Treatment of ANCA-Associated Vasculitis Coordinated by the APLAR Vasculitis SIG |
|
|
Chairpersons: TBC
Presentation title TBA Lai-Shan Tam Presentation title TBA Vanessa Ocampo Presentation title TBA Carlos Enrique Toro Gutiérrez |
|
|
|
|
1725-1730 |
Transition between sessions
|
|||
|
1730-1825 |
Evening symposium 1
Tacrolimus strategy for Autoimmune real-world in Rheumatic Disease |
Evening symposium 2
|
Evening symposium 3
The significance of IL-6 signal blocking in autoimmune diseases including RA |
Evening symposium 4
|
|
Sponsored by Novartis
|
Sponsored by Chugai Pharmaceutical / JW Pharmaceutical
|
|||
| Plenary / Concurrent 1 | Concurrent 2 | Concurrent 3 | Concurrent 4 | |||
|---|---|---|---|---|---|---|
|
0700 |
REGISTRATION
|
|||||
|
0830-1000
|
Plenary session 2: Translational Research and Artificial Intelligence in Rheumatology
Chairpersons: TBC Understanding rheumatic disease through continuous cell state analysis Soumya Raychaudhuri Artificial intelligence and machine learning in axial spondyloarthritis Denis Poddubnyy Digital healthcare regarding Rheumatic diseases Anindita Santosa |
|||||
|
1000-1025 |
BREAK |
Poster viewing |
||||
|
1025-1125
|
Morning symposium 5
Crossroads of Inflammation: What Advances in PsA/SpA Mean for Clinical Practice |
Morning symposium 6
From Inflammation to Impact: Early Treatment Strategies in Spondyloarthritis |
Morning symposium 7
Title coming soon |
Morning symposium 8
Title coming soon |
||
|
Sponsored by Johnson & Johnson
|
Sponsored by AbbVie
|
Sponsored by Medac
|
||||
|
1125-1130 |
Transition between sessions |
|||||
|
1130-1245 |
New horizon in lupus translational research
|
Imaging Coordinated by the APLAR Imaging SIG |
Epidemiology Coordinated by the APLAR Epidemiology SIG |
IJRD session Coordinated by the International Journal of Rheumatic Diseases |
||
|
Chairperson: TBC
The role of gut microbiome in systemic lupus erythematosus Seungki Kwok Q&A |
|
Chairperson: Yoshiya Tanaka and TBC
Do Epidemiological Factors Influence Treatment Outcomes in Rheumatoid Arthritis: Evidence from Clinical Practice Suleman Khan How and Why Vasculitis Differs Between East and West: Clinical and Epidemiological Insights Md Nazrul Islam |
Chairpersons: James Cheng-Chung Wei and Shin-Seok Lee
Opening & IJRD Statement for AI use in Medical Publication AI-Driven Systematic Reviews and Literature Synthesis Lisa Traboco EULAR recommendations on big data and AI in RMDs Latika Gupta Panel Discussion & Audience Q&A Closing remarks |
|||
|
1245-1250
|
Transition between sessions |
|||||
|
1250-1420 |
|
Lunch symposium 4
|
Lunch symposium 5
Title coming soon |
Lunch symposium 6
|
||
|
|
||||||
|
1420-1425
|
Transition between sessions |
|||||
|
1425-1540 |
SpA Coordinated by the APLAR SpA SIG |
Digital Health and Telemedicine Coordinated by the APLAR Digital Health and Telemedicine SIG |
Prevention and treatment of Infections in rheumatic diseases
|
Abstract session 2
|
||
|
Chairpersons: TBC
Unmet needs in axial Spondyloarthritis in 2026 Xenofon Baraliakos |
Chairpersons: Anindita Santosaand Faisal Parlindungan
Presentation title TBA Samuel L Whittle Presentation title TBA Mohsen G. Soroush TARDIS: The APLAR Telemedicine Survey Sakir Ahmed Q&A |
Chairpersons: TBC
Common infections in rheumatic diseases Chang-Hee Suh |
|
|||
|
1540-1610 |
BREAK |
Poster viewing |
||||
|
1610-1725 |
APLAR – ACR symposium Coordinated by ACR – International session |
Crystal-induced arthritis Coordinated by the APLAR Crystal-induced arthritis SIG |
Scleroderma Coordinated by the APLAR Scleroderma SIG |
Abstract session 3
|
||
|
Chairpersons: Yoshiya Tanaka and TBC
Childhood Lupus: Epidemiology and Emerging Treatments Hermine Brunner Q&A |
Chairperson: TBC and Kanon Jatuworapruk
CPPD – therapeutic frontiers: existing therapies, emerging biologics, and challenges in disease-modifying treatment in CPPD Geraldine McCarthy Metabolic Syndrome as the hidden driver of gout: Why every gout assessment must be a metabolic assessment Binit Vaidya Gout in complex comorbidity: CKD, heart disease and polypharmacy – practical treatment algorithms that reconcile CV safety, renal dosing, drug interactions and hospital formularies Lisa Stamp Q&A |
Chairpersons: Masataka Kuwana and Jasmin Raja
VEDOSS and Pre-systemic sclerosis: Predicting its progression (Title to be confirmed) Supraporn Wangkaew Vascular disease continuum in SSc: evidence, clinical meaningfulness and surrogate measures Francesco Del Galdo Q&A |
|
|||
|
1725-1730 |
Transition between sessions
|
|||||
|
1730-1825 |
Evening symposium 5
|
Evening symposium 6
|
Evening symposium 7
|
Evening symposium 8
|
||
|
Sponsored by Eisai
|
||||||
|
1900-Late |
Joint Presidential Gala dinner |
|||||
| Plenary / Concurrent 1 | Concurrent 2 | Concurrent 3 | Concurrent 4 | |||
|---|---|---|---|---|---|---|
|
0700 |
REGISTRATION
|
|||||
|
0800-0915 |
Rheumatoid arthritis Coordinated by the APLAR Rheumatoid arthritis SIG |
Paediatric Coordinated by the APLAR Paediatric SIG |
From Genes to Joints: Translating Genetic Discoveries into Practice Coordinated by the APLAR Genetics SIG |
How to treat Sjögren disease (SjD) Coordinated by the APLAR Sjogren SIG |
||
|
|
Chairpersons: Swee-Ping Tang and TBC
SLE Across the Age Spectrum: Can Adult Treatment Paradigms Be Applied to Children? Mary Beth Son Autoinflammatory Disorders in Children to Adults (title to be confirmed) Georgina Tiller Paediatric Bone Health and Osteoporosis: What Is the Evidence and How Does It Differ from Adults? Ma Theresa Collante Q&A |
Chairpersons: Michael Tee and Suleman Khan
Clinical Utility of Whole Genome Sequencing for the Diagnosis of Rheumatic Diseases Jeong Seok (Justin) Lee From Gene to Therapy: Functional Genomics and the Promise of Targeted Treatment in Monogenic Rheumatic Syndromes Fahd Adeeb Genetic Counselling in Rheumatic Diseases Michael Tee Q&A |
Chairpersons: Sandhya Pulukool and TBC
How to treat dryness of SjD, perspectives from rheumatologists Hiroto Tsuboi How to treat extra-glandular manifestations of SjD Sandhya Pulukool How to manage extra-glandular manifestations of SjD, especially pulmonary disease in SjD Seung-Ki Kwok Patient and Public Involvement in SjD Maureen Rischmueller |
|||
|
0915-0920 |
Transition between sessions |
|||||
|
0920-1050
|
Plenary session 3: Enhancing the Quality of Patient Care in Rheumatology
Chairpersons: TBC The Evolution and Prospects of the Collaboration between EULAR and APLAR Xenofon Baraliakos Improving Patient Outcomes through Evidence-based, Multidisciplinary Treatment Rachelle Buchbinder Enhancing Quality of Patient Care in Rheumatoid Arthritis: From Clinic to Research Ho-Youn Kim |
|||||
|
1050-1115 |
BREAK |
Poster viewing |
||||
|
1115-1230
|
Osteoporosis Coordinated by the APLAR Osteoporosis SIG |
Women’s Health & Reproductive Issues in RMDs Coordinated by the APLAR Women’s Health & Reproductive Issues in RMDs SIG |
Patient engagement with AI
|
How to manage extramuscular complications in idiopathic inflammatory myopathy Coordinated by the APLAR Myositis (IIM) SIG |
||
|
|
Chairpersons: TBC
APLAR Consensus Statements on the Management of Reproductive Issues in Rheumatic Diseases Vinod Ravindran Managing Lupus Nephritis in Pregnancy Samar Al Emadi |
Chairperson: TBC
Practical considerations in utilizing AI in medical research and practice Ji Seon Oh |
Chairpersons: Vidya Limaye and Ho So
Cancer screening -learning from the IMACS guideline Alex Oldroyd How to treat skin rash in dermatomyositis Amanda Saracino ILD management -learning from individual regional guidelines Takahisa Gono Q&A |
|||
|
1230-1235
|
Transition between sessions |
|||||
|
1235-1405
|
|
|
Lunch symposium 7
|
|
||
|
1405-1410
|
Transition between sessions |
|||||
|
1410-1525
|
RA-ILD
|
Abstract session 4
|
Allied health professionals
|
Abstract session 5
|
||
|
Chairperson: TBC
Biomarker and Imaging Insights into RA-ILD Progression Toshihiro Nanki Emerging Therapies and Safety in RA-ILD Jin-Woo Song Q&A |
|
|
|
|||
|
1525-1530 |
Transition between sessions
|
|||||
|
1530-1605 |
Closing ceremony and awards |
|||||
APLAR 2026 Information coming soon
Thank you for your patience as we prepare the necessary information for APLAR 2026.